Performance of steroid eluting bipolar epicardial leads in pediatric and congenital heart disease patients: 15 years of single center experience

Journal of Cardiothoracic Surgery

Roman Antonin Gebauer¹  Frank Thomas Riede¹  Patrick Flosdorff¹  Ingo Dähnert¹  Martin Kostelka²  Christian Paech¹ 

[1] Department for Pediatric Cardiology, University of Leipzig - Heart Center, Strümpellstr. 39, 04289 Leipzig, Germany;Department for Cardiac Surgery, University of Leipzig - Heart Center, Leipzig, Germany

关键词: Pediatrics;    Congenital heart disease;    Pacing;    Epicardial leads;   

Others  :  810306
DOI  :  10.1186/1749-8090-9-84

 received in 2013-11-14, accepted in 2014-05-05,  发布年份 2014

【 摘 要 】

Objective

Cardiac pacing is sometimes required for patients with congenital heart disease for various reasons. Because of complex anatomy, repetitive previous heart surgery and patient size, epicardial leads are of special importance in these patients. Using epicardial leads has been discussed controversly regarding pacing performance and lead survival. The aim of this study was to review the long-term data on pacing performance as well as lead survival of epicardial leads implanted in our center.

Methods

Retrospective chart review and review of the literature.

Results

82 consecutive pediatric patients or adult patients with congenital heart disease with 158 epicardial leads (Medtronic 4968, bipolar, steroid - eluting) were included. We found 1.2% pacemaker-related early postoperative complications. The incidence of lead dysfunction was 7.5% (12/158) for primary (i.e. directly related to the lead itself) lead dysfunction and 3.2% (5/158) of lead abandonment for reasons not directly related to the lead itself. Primary lead dysfunction occured after a median of 3.83 years. Lead survival at 2, 5 and 10 years was 98.7%, 93% and 92.4%. There were no infections reported. Stable median measurements for impedance (RA/RV/LV of 577/483/610 Ohm), sensing threshold (RA/RV/LV of 2.0/11.0/10.0 mV) and pacing threshold (RA/RV/LV of 0.75 V at 0.4 ms/1.0 V at 0.49 ms/1.0 V at 0.45 ms) indicated a good mid- to longterm performance. The only risk factor for primary lead dysfunction was young age at implantation.

Conclusion

The use of epicardial leads in pediatric and adult patients with congenital heart disease shows good longterm outcomes in terms of pacing performance and lead survival. The authors encourage using epicardial leads in patients with congenital heart disease based on the patient‘s individual characteristics.

【 授权许可】

   
2014 Paech et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Zartner PA, Wiebe W, Toussaint-Goetz N, Schneider MB: Lead removal in young patients in view of lifelong pacing. Europace 2010, 12:714-718.
• [2]Janousek J, van Geldorp IE, Krupicková S, Rosenthal E, Nugent K, Tomaske M, Früh A, Elders J, Hiippala A, Kerst G, Gebauer RA, Kubus P, Frias P, Gabbarini F, Clur SA, Nagel B, Ganame J, Papagiannis J, Marek J, Tisma-Dupanovic S, Tsao S, Nürnberg JH, Wren C, Friedberg M, de Guillebon M, Volaufova J, Prinzen FW, Delhaas T: Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study. Working Group for Cardiac Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology. Circulation 2013, 127(5):613-623.
• [3]Riede FT, Kostelka M, Dähnert I: Cardiac strangulation: a rare, but devastating complication of epicardial pacing causing progressive myocardial ischaemia. Eur Heart J 2009, 30(4):435.
• [4]Tomaske M, Gerritse B, Kretzers L, Pretre R, Dodge-Kathami A, Rahn M, Bauersfeld U: A 12-year experience of bipolar steroid-eluting epicardial pacing leads in children. Ann Thorac Surg 2008, 85(5):1704-1711.
• [5]Walker F, Siu SC, Woods S, Cameron DA, Webb GD, HARRIS L: Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol 2004, 43(10):1894-1901.
• [6]Lichtenstein BJ, Bichell DP, Connolly DM, Lamberti JJ, Shepard SM, Seslar SP: Surgical approaches to epicardial pacemaker placement: does pocket location affect lead survival? Pediatr Cardiol 2010, 31(7):1016-1024.
• [7]Silvetti MS: Twenty years of paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292 patients. Europace 2006, 8(7):530-536.
• [8]Post MC, Budts W, Bruaene A, Willems R, Meyns B, Rega F, Gewillig M: Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict. Neth Heart J 2011, 19(7–8):331-335.
• [9]Murayama H, Maeda M, Sakurai H, Usui A, Ueda Y: Predictors affecting durability of epicardial pacemaker leads in pediatric patients. J Thorac Cardiovasc Surg 2008, 135(2):361-366.
• [10]Odim J, Suckow B, Saedi B, Laks H, Shannon K: Equivalent performance of epicardial versus endocardial permanent pacing in children: a single institution and manufacturer experience. Ann Thorac Surg 2008, 85(4):1412-1416.
• [11]Fortescue EB, Berul CI, Cecchin F, Walsh EP, Triedman JK, Alexander ME: Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. J Interv Card Electrophysiol 2005, 14(1):27-36.
• [12]Batra AS, Balaji S: Pacing in adults with congenital heart disease. Expert Rev Cardiovasc Ther 2006, 4(5):663-670.
• [13]Kwak JG, Kim SJ, Song JY, Choi EY, Lee SY, Shim WS, Lee CH, Lee C, Park CS: Permanent epicardial pacing in pediatric patients: 12-year experience at a single center. Ann Thorac Surg 2012, 93(2):634-639.
• [14]Kubus P, Materna O, Gebauer RA, Matejka T, Gebauer R, Tlaskal T, Janousek J: Permanent epicardial pacing in children: long-term results and factors modifying outcome. Europace 2012, 14(4):509-514.
• [15]Janousek J, van Geldorp IE, Krupickova S, Rosenthal E, Nugent K, Tomaske M, Früh A, Elders J, Hiippala A, Kerst G, Gebauer RA, Kubus P, Frias P, Gabbarini F, Clur SA, Nabel B, Ganame J, Papagiannis J, Marek J, Tisma-Dupanovic S, Tsao S, Nürnberg JH, Wren C, Friedberg M, de Guillebon M, Volaufova J, Prinzen FW, Delhaas T, Working Group for Cardiac Dysrhythmias and Electrophysiology of the Association for Pediatric Cardiology: Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study. Circulation 2013, 127(5):613-623.